Clinical Trials in Houston

Showing 3781-3800 of 16,518 trials

Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families

NCT07170163

The purpose of this study is to determine useability and satisfaction characteristics,product usage data,methodological feasibility parameters and feasibility metrics of the mHealth app adapted intervention on the mental health, quality of life, and adaptive functioning of Latino transition aged young adults with ASD and their parents.

Autism Spectrum Disorder (ASD)

The University of Texas Health Science Center, Houston30 participantsStarted Jun 2026

Houston, Texas, United States

RECRUITINGNA< 1 mile

A Neurosensory Account of Anxiety and Stress (Study 1)

NCT05895006

This study will take a basic neuroscience approach to investigate pathological mechanisms underlying PTSD. Additionally, the study aims to identify how Transcranial Alternating Current Stimulation (tACS) brain stimulation can modulate and correct neural networks and related emotions of anxious arousal and hypervigilance, with the goal of assessing tACS brain stimulation technology as a novel intervention for symptoms of anxiety.

Posttraumatic Stress Disorder (PTSD)Intrinsic and Novelty-related Sensory Cortical (SC) Disinhibition

The University of Texas Health Science Center, Houston160 participantsStarted Apr 2022

Houston, Texas, United States

Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families

A Neurosensory Account of Anxiety and Stress (Study 1)

Find Trials by Condition in Houston

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

Histological Evaluation in the Efficacy of GentleWave in Root Canal Pulp Tissue Debridement and Disinfection of Difficult to Reach Areas in Mandibular Human Molars II. An In-vivo Study.

Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug

Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older

Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease

A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)

A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy

A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer

First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Study of Lademirsen (SAR339375) in Patients With Alport Syndrome

Use of Stromal Vascular Fraction in Multiple Sclerosis

Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders